Mark R Bamforth Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark R Bamforth.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark R Bamforth. Mark R Bamforth is Sr.VP, Corp. Operations & Phar in GENZYME CORP ($GENZ) and Director in PEREGRINE PHARMACEUTICALS INC ($PPHM).
Latest Insider Trading Transactions of Mark R Bamforth
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2021 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Buy | P | 18.18 | 126,000 | 2,290,680 | 126,000 | 0 to 126 K |
| Mar 19 2021 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Sell | S | 18.18 | 26,000 | 472,680 | 0 | 26 K to 0 (-100.00 %) |
| Mar 19 2021 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Sell | S | 18.18 | 100,000 | 1,818,000 | 0 | 100 K to 0 (-100.00 %) |
| Dec 16 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
| Dec 16 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 124,305 | |
| Mar 16 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Buy | P | 4.01 | 26,000 | 104,260 | 26,000 | 0 to 26 K |
| Jan 13 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
| Jan 13 2020 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
| Dec 18 2018 | PPHM | Avid Bioservices, ... | Bamforth Mark R | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.51 | 1,200 | 5,412 | 50,000 | 48.8 K to 50 K (+2.46 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.51 | 35,966 | 162,063 | 48,800 | 12.8 K to 48.8 K (+280.24 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 5,340 | 23,993 | 12,834 | 7.5 K to 12.8 K (+71.26 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 201 | 903 | 7,494 | 7.3 K to 7.5 K (+2.76 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 300 | 1,347 | 7,293 | 7 K to 7.3 K (+4.29 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 1,800 | 8,080 | 6,993 | 5.2 K to 7 K (+34.66 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.49 | 4,993 | 22,399 | 5,193 | 200 to 5.2 K (+2,496.50 %) |
| Oct 27 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Buy | P | 4.48 | 200 | 895 | 200 | 0 to 200 |
| Oct 24 2017 | PPHM | PEREGRINE PHARMACE ... | Bamforth Mark R | Director | Option Exercise | A | 3.88 | 75,000 | 291,000 | 75,000 | |
| Mar 06 2009 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Buy | P | 54.54 | 700 | 38,178 | 3,775 | 3.1 K to 3.8 K (+22.76 %) |
| Aug 15 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | M | 43.90 | 19,200 | 842,880 | 0 | |
| Aug 15 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | M | 41.50 | 32 | 1,328 | 0 | |
| Aug 15 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Sell | S | 81.71 | 19,232 | 1,571,447 | 158 | 19.4 K to 158 (-99.19 %) |
| Aug 15 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Buy | M | 41.50 | 32 | 1,328 | 19,390 | 19.4 K to 19.4 K (+0.17 %) |
| Aug 15 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Buy | M | 43.90 | 19,200 | 842,880 | 19,358 | 158 to 19.4 K (+12,151.90 %) |
| Aug 07 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | M | 32.52 | 6,445 | 209,591 | 0 | |
| Aug 07 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Sell | S | 79.00 | 6,445 | 509,155 | 158 | 6.6 K to 158 (-97.61 %) |
| Aug 07 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Buy | M | 32.52 | 6,445 | 209,591 | 6,603 | 158 to 6.6 K (+4,079.11 %) |
| Jul 17 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | M | 32.52 | 6,445 | 209,591 | 12,890 | |
| Jul 17 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Sell | M | 79.00 | 6,445 | 509,155 | 158 | 6.6 K to 158 (-97.61 %) |
| Jul 17 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Grant | A | 0.00 | 6,445 | 0 | 6,603 | 158 to 6.6 K (+4,079.11 %) |
| May 27 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| May 27 2008 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | A | 68.48 | 15,000 | 1,027,200 | 15,000 |
Page: 1